Simplex Trading’s Medline Inc MDLN Stock Holding History

Simplex Trading’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-27,297	Closed	-$1.21M	–	10500
2025 Q4	$1.15M	Buy	+27,297	New	+$1.15M	﹤0.01%	2500

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

HFCIX

H&F Corporate Investors X San Francisco, California $2.8B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Simplex Trading's MDLN Position: Q1 2026 in Review

Simplex Trading sold out of Medline Inc (MDLN) in Q1 2026, closing a stake of 27,297 shares — an estimated $1.21M sold.

Simplex Trading first reported a position in MDLN in Q4 2025 and held it in 1 quarter. The position peaked at $1.15M in Q4 2025. 314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

Simplex Trading reported no remaining Medline Inc position as of Q1 2026 after selling out during the quarter.
Simplex Trading sold 27,297 Medline Inc shares in Q1 2026, an estimated $1.21M.
Simplex Trading first reported a position in Medline Inc in Q4 2025 and held it in 1 quarter.
Simplex Trading's Medline Inc position peaked at $1.15M in Q4 2025.
314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.